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Interactions between COVID-19 and other pathogens may change their 
dynamics. Specifically, this may hinder the modelling of empirical data when 
the symptoms of both infections are hard to distinguish. We introduce a model 
coupling the dynamics of COVID-19 and seasonal influenza, simulating 
cooperation, competition and asymmetric interactions. We find that the 
coupling synchronizes both infections, with a strong influence on the 
dynamics of influenza, reducing its time extent to a half. 
 
The COVID-19 outbreak, declared as a pandemic on March 11, 2020 by the             
World Health Organization, is challenging the scientific community, from the forecast           
and design of non-pharmaceutical interventions to the fast development of efficient           
treatments and vaccines. In fact, at the end of July 2020, there were more than 17                
million confirmed cases around the world, which has led to more than 0.6 million              
deaths, according to the global data platform developed by John Hopkins University. 
One of the uncertainties about COVID-19 is how this infection interacts with            
other infections in the hosts. Interactions can be neutral, such that the infections are              
independent and they do not modify mutually their behaviours, competitive or           
cooperative. Competitive interactions are typically associated with cross-immunity,        
such that one individual that has been infected with one disease has a lower              
infection rate for the other, although they can be related with non-pharmaceutical            
interventions such as isolation. In contrast, cooperative effects represent the          
weakening of individuals, such that they are more likely to acquire secondary            
infections, commonly known as co-infection; this is something that can also happen            
when the symptoms of both infections are hard to distinguish and the patients share              
space at the hospitals.  
Several mathematical models analyse the effects of interactions between         
pairs of infections [1,2]. In these models, individuals that have been infected by one              
disease display a modified infection rate with respect to the other disease, such that              
the infection rates of infected or recovered individuals are different from those of             
susceptible individuals. In fact, interactions between infections have been reported          
for pairs such as leprosy-tuberculosis [3], tuberculosis-HIV [4], hepatitis-HIV [5], or           
zika and dengue [6]. 
We model the interaction between the spreading processes of COVID-19 and           
seasonal influenza. The independent COVID-19 infection is modelled as a SEIR           
(Susceptible-Exposed-Infected-Recovered) dynamics, such that susceptible     
individuals in contact with infected individuals become exposed with a rate β ​c​,            
spontaneously become infected with a rate 1/τ ​Ec and recover from the infected state             
with a rate 1/τ​c . The dynamics of independently spreading influenza is described by              
the SIR (Susceptible-Infected-Recovered) model, analogous to that of COVID-19 but          
without the exposed state, with an infection rate β​i and a recovery rate 1/τ ​i . We                
consider the deterministic mean-field equations describing these processes,        
extracting the parameters from the literature (Table I, [7,8]). The interaction implies            
that individuals that are not susceptible to COVID-19 (influenza) become infected           
with influenza (COVID-19) with a rate k​i ​β​i (k​c β​c ) (Fig. 1). Values of k ​i and k​c higher                   
than 1 represent a cooperative interaction (known as co-infection), while values that            
are lower than 1 describe competitive interactions, typically introduced as          
cross-immunity, although this can also illustrate the non-pharmaceutical intervention         
of keeping infected individuals in quarantine and, hence, isolating them from the            
other pathogen. 
The dynamics describing the temporal evolution of the 12 states introduced in            
Fig. 1 is simplified in the dynamics of 8 variables: s = [S], e​c = [E​c ]+[E​c I​i​]+[E​c R​i​], q​c =                     
[I​c ]+[I​c I​i​]+[I ​c R​i​], t​c = [E ​c​]+[I ​c ]+[R​c​], f​c = [R​c​]+[R ​c I​i​]+[R​c R​i​], q​i = [I​i​]+[E​c I​i​]+[I​c I​i​]+[R​c I​i​], t​i                    
= [I​i​]+[R​i​], and f​i = [R​i​]+[E​c R​i​]+[I ​c R​i​]+[R​c R​i​], where the brackets indicate the density               
of individuals in that state. These variables evolve according to the following system             
of ordinary differential equations: 
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We numerically integrate the equations describing this dynamics, starting from          
the initial condition s(t=0) = 1−ϵ, q​c (t = 0) = t​c (t = 0) = q​i (t = 0) = t​i (t = 0) = ϵ/2, e​c (t =                              
0) = f​c​ (t = 0) = f​i​ (t = 0) = 0, with ϵ = 0.01. 
First, we analyse the non-interacting scenario (k​i = k​c = 1), observing that the              
dynamics of COVID-19 reaches a higher peak before the peak of influenza (Fig. 2).              
Specifically, it takes influenza twice the time that it takes COVID-19 to reach its peak,               
with the prevalence at the peak of COVID-19 being 5 times higher than that              
displayed at the peak of influenza. We observe that, under this mean-field dynamics,             
the COVID-19 reaches all the population along with this infection wave (cumulative            
prevalence f​c higher than 98%), while influenza reaches a cumulative prevalence f​i of             
44% (see Supplementary Text 1, Fig. 2 inset), such that under the mean-field             
well-mixed assumption, the cumulative prevalence of people with both infections          
approaches f ​i . The simplification of our model of 12 states into a set of 8 differential                 
equations does not allow us to isolate the number of individuals affected by at least               
one active infection, but we approximate it by Q = q​c + q​i , which is a maximum                  
bound of it and a good estimator as far as [I​c I​i ] is low. This parameter reaches its                   
peak close to the peak of COVID-19, and displays a long tail due to the slower                
spreading of influenza (Fig. 2). 
In the interactive scenarios, the COVID-19 infection dominates the dynamics,          
and its prevalence curve does not change considerably due to the interactions, but it              
influences that of influenza (Fig. 3). Specifically, when the interaction is competitive            
for the infection of COVID-19 (k​c < 1), the time at which the maximum prevalence of                
COVID-19 is reached does not significantly change (variations smaller than 0.2           
days), and it has a slightly lower prevalence (relative decrease in 2% of k​i​=0.5 and               
4% for k​i​=2, Fig. 3a,b), with the opposite behaviour for cooperative infections            
(relative increase in 2% for k​i​=0.5 and 3% for k​i​=2, Fig. 3c,d), but without              
experiencing major changes in the peak prevalence. In contrast, competitive          
interactions in the influenza infection (k​i < 1) considerably reduce the peak (relative             
decrease in 68% for both k​c​=0.5 and k​c​=2) and the time taken to reach it (from 41.60                 
days to 15.40 and 15.15 days for k​c​=0.5 and k​c​=2, respectively, Fig. 3a,c), because              
as the COVID-19 infection initially grows faster than the influenza infection, the            
competitive interaction flattens the prevalence curve of influenza. The cooperative          
interaction for influenza infection (k​i > 1) also reduces the time taken to reach its               
maximum prevalence (28.91 and 28.68 days for k​c​=0.5 and k​c​=2, respectively) but            
increases the height of this peak (relative increases in 500% and 509% for k​c​=0.5              
and k​c​=2, respectively, Fig. 3b,d). When we consider the variable Q = q​c + q​i , which                 
is a good estimator of the demand in the health care centres, we realize that first, the                 
temporal extent of the dynamics is halved, from approximately 100 to 50 days, and              
that this demand is affected by k​i​, such that k​i = 0.5 slightly reduces the peak                
demand and k​i​ = 2 increases it in a factor 1.5 (Fig. 3 insets). 
Interaction between the infections of COVID-19 and influenza is translated          
into a synchronization of their temporal behaviours, driven by the COVID-19           
infection, which initially grows faster (Fig. 2). We explore the prevalence at the peaks              
q​M and their arrival times T​M in two cases: an asymmetric interaction (k​c = 1, k​i                
variable), and a symmetric interaction (k​c = k​i variable). In the asymmetric scenario,             
any interaction (k​i > 1), decreases the arrival time of the influenza peak (Fig. 4a).               
Interestingly, this interaction makes the prevalence of influenza higher than that of            
COVID-19, and it reaches a maximum for k​i = 5.8, with also the influenza peak               
arriving earlier than that of COVID-19, such that the influenza prevalence curve            
could be interpreted as an early-warning of the COVID-19 curve, arriving later due to              
the exposure period. In the symmetric interaction, we find a similar behaviour for             
influenza, while COVID-19 does not substantially modify the arrival time of its peak,             
and there is more variation on its peak intensity, even if the change of values is                
much lower than the observed for influenza (Fig. 4b). We observe an optimal value              
for the interaction parameter k​i in both cases such that the peak of influenza displays               
a maximum prevalence, interpreted as a resonance between both infection          
processes, such that if k​i is higher, the peak of influenza will occur earlier, but in a                 
moment where the fraction of exposed individuals to COVID-19 is not maximum yet. 
Mathematical modelling of infectious diseases is becoming a fundamental tool          
for forecasting and policy-making, leading to a remarkable effort for revealing the            
statistical properties of the models of spreading dynamics [9]. In fact, the interaction             
between multiple infections represents an additional degree of complexity. Our          
model illustrates the interaction between two infections described by different          
dynamics in their independent spread. We recognize that this work has some            
limitations. First, it considers a mean-field dynamics without focusing on the           
interaction network, with details leading to a rich dynamics in the frame of interactive              
infections in static complex networks [10] or temporal networks [11]. Additionally, we            
consider that the interaction modifies the infection rates, while an extended model            
would include the effects of the interaction in recovery rates, as observations reflect             
that coinfection of SARS-CoV-2 and other pathogens leads to longer lengths of the             
hospitalary stays [12]. 
Research on the interactions of COVID-19 with other infections is still           
ongoing. Indeed, the competitive process due to the cross-immunity is controversial,           
as the immune system displays different response pathways to COVID-19 and           
influenza [13], in contrast to recent reports that revealed that T cells related to the               
immune response to common cold coronaviruses react against SARS-CoV-2 [14,15].          
Regarding coinfection of SARS-CoV-2 and other respiratory pathogens, empirical         
observations reported a reduced frequency of other pathogens in individuals that           
were tested positive for SARS-CoV-2 (20.7%) in contrast to the frequency in those             
tested negative (26.7%) [16], while other observations reported even lower          
frequencies of other respiratory pathogens, represented by 2.99% for individuals          
tested positive and 13.1% for individuals tested negative [17].  
Apart from the biomedical interpretation of the interactions, our well-mixed          
framework may include the effects of non-pharmaceutical interventions, leading to a           
reduced prevalence of other diseases, such as influenza, due to the preventive            
lockdown against the spreading of COVID-19 [18,19], the slowing down of           
vaccination campaigns against other infections, thus facilitating their spread [20], or           
the disruption on treatment and preventive actions against HIV [21].  
We have shown a synchronization process between COVID-19 and influenza.          
In fact, correlations between the empirical number of positive-tested patients of           
COVID-19 and excess influenza-like illness cases have been reported [22,23], which           
could emerge either from considering non-positive COVID-19 patients within those          
cases or from the synchronization between COVID-19 and influenza-like illness          
outbreaks. Our results reveal how the prevalence information from other infections           
may inform us about the evolution of COVID-19 outbreaks and, at the same time,              
facilitate the inference of the prevalence curve when the reporting managers are not             
able to distinguish between the symptoms of the considered interacting infections.  
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Tables 
 
Infection Infection rate  
(days​-1​) 
Exposure 
time 
(days) 
Infection time 
(days) 
Ref. 
COVID-19 β​c​ = 1.12 τ​Ec​ = 3.69 τ​c​ = 3.47 [7] 
Seasonal 
influenza 
β​i​ = 0.32 x τ​i​ = 4.1 [8] 
Table I. Parameters extracted from the literature for the dynamics of COVID-19 and 
seasonal influenza. 
  
Figures 
 
Fig. 1. ​Scheme of the dynamics. The letters inside the circles denote the 12 possible               
states in the SEIR-SIR dynamics, the letters over the arrows represent the transition             
rates between the states, and the arrow colors depict the exposure to other states              
necessary for each transition, with black, orange and blue colors representing,           
respectively, spontaneous processes, processes under the exposure to the         
COVID-19 infected population, and processes under the exposure to the population           
infected with influenza.  
 
 
 
Fig. 2. ​Temporal series of the fraction of infected individuals q for COVID-19 and              
influenza in the case of non-interacting infections, i.e. k​c = k​i = 1. The dashed lines                
represent the peak of infected individuals for COVID-19 (orange), influenza (blue)           
and both (Q = q ​c + q​i​, black). Inset: temporal series of the cumulative prevalence f of                 
COVID-19 and influenza.  
 
Fig. 3. ​Temporal series of the fraction of infected individuals q for COVID-19 and              
influenza in the interactive scenarios ​a, both experience competitive effects k​c = k​i =              
0.5, ​b, k​c = 0.5, k​i = 2, ​c, k ​c = 2, k​i = 0.5, ​d, both experience cooperative effects k​c = k​i                       
= 2. Insets: fraction of individuals Q = q​c + q​i affected by at least one infection. Dotted                  
lines represent the case k​c = k​i = 1, while continuous lines correspond to each case                
in ​a-d​.  
 
Fig 4. ​Phase diagram of the prevalence at the peak q​M and the time T​M at which the                  
peak is reached, for different interacting scenarios. ​a, k​c = 1, varying k ​i and ​b, varying                
the interaction strengths k ​c and k​i under the constraint k​c = k​i . The vertical dashed                
line is the analytical prediction for the maximum prevalence of influenza with k​i = 1               
(see Supplementary Text 2). Circles and triangles represent, respectively, the values           
associated with influenza and COVID-19, colors indicate the interaction strength and           
the symbols with black perimeters correspond to the case k​c​ = k ​i​ = 1.  
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Supplementary Text 1 
 
Considering a Susceptible-Infected-Recovered (SIR) dynamics, described by 
− sidt
ds = β  
si idt
di = β − τ −1  
idt
dr = τ −1  
 
we obtain which, taking into account s(t = 0) = s​0 and r(t = 0) = 0, leads to  − τsdr
ds = β                   
s(t) = s ​0 e ​−βτ r(t) , and considering s(t → ∞) + r(t → ∞) = 1, we obtain the non-linear                      
equation r(t → ∞) = 1 − s​0​ e​−βτ r(t→∞)​. 
Solving numerically this equation with the parameters s​0 = 1− ϵ/2, ϵ = 0.01, β               
= 0.32 and τ = 4.1, we obtain r(t → ∞) ≈ 0.445. 
 
Supplementary Text 2 
 
Considering a SIR model, with the evolution described in Supplementary Text           
1, the maximum value of the fraction of infected is obtained imposing di/dt = 0, which                
leads to s​p = 1/βτ, where the subindex p indicates the value at the peak. Considering                
s(t) = s ​0 e ​−βτ r(t) ​and s​p + i​p + r​p = 1, we obtain i​p = 1 −1/R(1 + log s ​0​/R), where R = 1/βτ                           
is the basic reproductive number.  
Substituting s​0 = 1 − ϵ/2, with ϵ = 0.01 and the parameters detailed in Table I,                 
we obtain i​p​ ≈ 0.0346. 
 
 
 
 
 
 
 
 
 
